Article PDF
Avoid common mistakes on your manuscript.
Literatur
Steiner TJ, Stovner LJ, Vos T. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain. 2016;17:104
Müller-Vahl K, Grotenhermen F. Medizinisches Cannabis. Die wichtigsten Änderungen. Dtsch Arztebl. 2017;114:A352–6
Baron EP. Comprehensive review of medicinal marijuana, cannabinoids, and therapeutic implications in medicine and headache: what a long strange trip it’s been. Headache. 2015;55:885–916
Soyka M, Preuss U, Hoch E. Cannabisinduzierte Störungen. Nervenarzt. 2017;88:311–25
Fischer B, Russell C, Sabioni P et al. Lower-risk cannabis use guidelines: a comprehensive update of evidence and recommendations. Am J Public Health. 2017;107:e1–12
Ducros A, Boukobza M, Porcher R et al. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007;130:3091–101
Whiting PF, Wolff RF, Deshpande S et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA. 2015;313:2456–73
Lochte BC, Beletsky A, Samuel NK, Grant I. The use of cannabis for headache disorders. Cannabis Cannabinoid Res. 2017;2:61–71
Pini LA, Guerzoni S, Cainazzo MM et al. Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial. J Headache Pain. 2012;13:677–84
Leroux E, Taifas I, Valade D et al. Use of cannabis among 139 cluster headache sufferers. Cephalalgia. 2013;33:208–13
Author information
Authors and Affiliations
Corresponding author
Additional information
Online-Version des Originalartikels: http://dx.doi.org/10.1007/s15006-018-0329-z
Rights and permissions
About this article
Cite this article
Förderreuther, S. Erratum zu „Cannabinoide gegen Kopfschmerzen?“. MMW - Fortschritte der Medizin 160, 28 (2018). https://doi.org/10.1007/s15006-018-0017-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15006-018-0017-z